Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I

NCT ID: NCT00071656

Last Updated: 2013-08-09

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 60 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2002-09-30
• Study Completion Date: 2007-06-30

Brief Summary

The purpose of this study is to develop and implement a treatment that focuses on behaviors to reduce symptom severity and functional impairment in patients with Attention Deficit Hyperactivity Disorder, Predominantly Inattentive Type (ADHD-I). The long-term goal of this study is to apply the treatment to larger-scale trials to determine its effectiveness and generalizability.

Detailed Description

ADHD-I is a highly prevalent and serious childhood disorder that affects academic and social development. The symptoms of ADHD-I differ from those of the well-studied ADHD Combined Type. Unfortunately, studies of psychosocial interventions for ADHD-I are currently unavailable. Effective treatments for ADHD-I are still needed.

Participants are randomly assigned to receive either a behavioral intervention or treatment as usual for 10 to 12 weeks. The behavioral intervention includes parent and child skill development groups, family meetings, and consultation with the child's teacher to address attention problems and areas of impairment at home and school. Parent and child interviews, teacher and child ratings, and psychoeducational testing are used to assess participants. Participants are assessed post-treatment and at a 2-month follow-up visit.

Conditions

Attention Deficit Disorder With Hyperactivity

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT

Interventions

Psychosocial (behavioral) Intervention

Intervention Type: BEHAVIORAL

Eligibility Criteria

Inclusion Criteria

• ADHD, Predominantly Inattentive Type
• Public or private school attendance
• English speaking

• Minimum Eligible Age: 7 Years
• Maximum Eligible Age: 11 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

National Institute of Mental Health (NIMH)

NIH

Sponsor Role: collaborator

University of California, San Francisco

OTHER

Sponsor Role: lead

Locations

HALP Clinic, Children's Center at Langley Porter, UCSF

San Francisco, California, United States

Countries

United States

Other Identifiers

R21MH065927

Identifier Type: NIH

Identifier Source: secondary_id

View Link

DSIR CT-S

Identifier Type: -

Identifier Source: secondary_id

R21MH065927

Identifier Type: NIH

Identifier Source: org_study_id

View Link